Souri, Z.; Jochemsen, A.G.; Versluis, M.; Wierenga, A.P.A.; Nemati, F.; van der Velden, P.A.; Kroes, W.G.M.; Verdijk, R.M.; Luyten, G.P.M.; Jager, M.J.
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma. Cancers 2020, 12, 3690.
https://doi.org/10.3390/cancers12123690
AMA Style
Souri Z, Jochemsen AG, Versluis M, Wierenga APA, Nemati F, van der Velden PA, Kroes WGM, Verdijk RM, Luyten GPM, Jager MJ.
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma. Cancers. 2020; 12(12):3690.
https://doi.org/10.3390/cancers12123690
Chicago/Turabian Style
Souri, Zahra, Aart G. Jochemsen, Mieke Versluis, Annemijn P.A. Wierenga, Fariba Nemati, Pieter A. van der Velden, Wilma G.M. Kroes, Robert M. Verdijk, Gregorius P.M. Luyten, and Martine J. Jager.
2020. "HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma" Cancers 12, no. 12: 3690.
https://doi.org/10.3390/cancers12123690
APA Style
Souri, Z., Jochemsen, A. G., Versluis, M., Wierenga, A. P. A., Nemati, F., van der Velden, P. A., Kroes, W. G. M., Verdijk, R. M., Luyten, G. P. M., & Jager, M. J.
(2020). HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma. Cancers, 12(12), 3690.
https://doi.org/10.3390/cancers12123690